Parkinson's disease (PD) is one of the most important neurodegenerative worldwide disorders. The potential cytoprotective effects of aqueous extract of Valeriana officinalis on rotenone-induced apoptosis in human neuroblastoma SH-SY5Y cells were demonstrated. The cytotoxicity, cell viability and analysis of cellular morphology were performed by MTT-tetrazole (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay and phase contrast microscopy, respectively. Significant changes in the cellular morphology, and condensation of the cell body could be observed when cells were treated with 300 nM rotenone for 48 h. Three different concentrations of Valeriana officinalis extract were used (0.049, 0.098 and 0.195 mg/mL). These extracts brought about an increase of 7.0 +/- 1.3%, 14.5 +/- 1.3% and 14.5 +/- 3.2% in cell viability. Our results indicated that neuroprotector action of the Valeriana officinalis extract provides support for later studies as they help understanding this drug for the development of cytoprotective various therapies in PD.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s11064-008-9749-y | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Isobicyclogermacrenal ameliorates hippocampal ferroptosis involvement in neurochemical disruptions and neuroinflammation induced by sleep deprivation in rats.
Phytomedicine
November 2024
College of Pharmaceutical Science, Hebei University, Baoding 071002, China; State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, China; Key Laboratory of Medicinal Chemistry and Molecular Diagnosis of the Ministry of Education, Hebei University, Baoding 071002, China. Electronic address:
Background: Sleep deprivation (SLD) is a widespread condition that disrupts physiological functions and may increase mortality risk. Valeriana officinalis, a traditional medicinal herb known for its sedative and hypnotic properties, contains isobicyclogermacrenal (IG), a newly isolated active compound. However, research on the therapeutic potential of IG for treating SLD remains limited.
View Article and Find Full Text PDFComplete genome sequence of Valeriana jatamansi cryptic virus 1: a novel member of the genus Alphapartitivirus infecting Valeriana jatamansi Jones.
Arch Virol
December 2024
Key Laboratory for Agricultural Bioaffiliationersity for Pest Management of China, Ministry of Education, Yunnan Agricultural University, NO. 95, Jinhei Road, Panlong District, Kunming, Yunnan, 650201, China.
Article Synopsis
- A new dsRNA virus called "Valeriana jatamansi cryptic virus 1" (VJCV1) was found in Valeriana jatamansi plants showing symptoms in Yunnan, with its complete genome sequenced.
- VJCV1 has two segments of dsRNA, which code for an RNA polymerase and a coat protein, and features unique structures typical of the Alphapartitivirus genus.
- Phylogenetic analysis indicates that VJCV1 is distinct from other known viruses in the genus, suggesting it should be classified as a new species within Alphapartitivirus, marking the first virus from this group identified in Valeriana plants.
Mechanism of extract improving atherosclerosis by regulating PGC-1α/Sirt3/Epac1 pathway.
Front Pharmacol
November 2024
Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Article Synopsis
- The study aimed to evaluate how a specific extract protects against mitochondrial damage in mice with atherosclerosis, focusing on its chemical composition and efficacy using advanced analytical techniques.
- Results showed that the extract significantly boosted heart and mesenteric microcirculation, lowered harmful lipid levels, and enhanced ATP levels, indicating improved mitochondrial function and lipid metabolism.
- The mechanism behind these effects involves the PGC-1α/Sirt3/Epac1 signaling pathway, with the extract increasing beneficial protein markers while reducing those associated with cell death.
Peribronchial Inflammatory Cell Assessment in COPD Lung Tissues.
J Cell Mol Med
November 2024
University of Reims Champagne-Ardenne (URCA), Inserm UMR-S 1250, SFR Cap-Santé, Reims, France.
[Atypical and/or systemic dermatologic disorders related to immune checkpoint inhibitors: A review].
Rev Med Interne
November 2024
Service de médecine interne et immuno-pathologie, IUCT - Oncopôle, CHU de Toulouse, 1, avenue Joliot-Curie, 31100 Toulouse, France.
Article Synopsis
- Immunological checkpoint inhibitors, used in treating various cancers, can cause toxic side effects, particularly dermatological disorders.
- Common skin issues like maculopapular erythema and pruritus often occur, but rarer conditions such as fasciitis and scleroderma can also arise.
- Recognizing these unusual manifestations is crucial for internists, as they may mimic other diseases or paraneoplastic syndromes, requiring specific diagnostic and treatment approaches related to ICI toxicity.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!